| Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis E Du Bruyn, S Ruzive, CS Lindestam Arlehamn, A Sette, A Sher, ... Mucosal immunology 14 (2), 491-499, 2021 | 42 | 2021 |
| Disease extent and anti‐tubercular treatment response correlates with Mycobacterium tuberculosis‐specific CD4 T‐cell phenotype regardless of HIV‐1 status C Riou, E Du Bruyn, S Ruzive, RT Goliath, CS Lindestam Arlehamn, ... Clinical & Translational Immunology 9 (9), e1176, 2020 | 39 | 2020 |
| changes in host immune–endocrine relationships during Tuberculosis Treatment in Patients with cured and Failed Treatment Outcomes L Kleynhans, S Ruzive, L Ehlers, L Thiart, NN Chegou, M Conradie, ... Frontiers in immunology 8, 690, 2017 | 14 | 2017 |
| Tuberculosis infection and disease in South African adolescents with perinatally acquired HIV on antiretroviral therapy: a cohort study LJ Frigati, KA Wilkinson, S le Roux, K Brown, S Ruzive, L Githinji, ... Journal of the International AIDS Society 24 (3), e25671, 2021 | 12 | 2021 |
| Comparison of the frequency and phenotypic profile of Mycobacterium tuberculosis-specific CD4 T cells between the site of disease and blood in pericardial tuberculosis. E Du Bruyn, S Ruzive, P Howlett, AJ Jacobs, CSL Arlehamn, A Sette, ... The Francis Crick Institute, 2022 | 4 | 2022 |
| Communicable and non-communicable co-morbidities and the presentation of COVID-19 in an African setting of high HIV-1 and tuberculosis prevalence E du Bruyn, C Stek, R Daroowala, Q Said-Hartley, M Hsiao, RT Goliath, ... medRxiv, 2021.05. 11.21256479, 2021 | 4 | 2021 |
| Blood and site of disease inflammatory profiles differ in pericardial tuberculosis patients with HIV-1 H Mutavhatsindi, E Du Bruyn, S Ruzive, P Howlett, M Cerrone, A Sher, ... Open Forum Infectious Diseases, ofad128, 2023 | 1* | 2023 |
| Profile of Mycobacterium tuberculosis-specific CD4 T cells at the site of disease and blood in pericardial tuberculosis E Du Bruyn, S Ruzive, P Howlett, AJ Jacobs, CS Lindestam Arlehamn, ... BioRxiv, 2022.05. 12.491749, 2022 | 1 | 2022 |
| An evaluation of the recommendations for primary nutrition research addressing noncommunicable disease using the EPICOT+ framework: A cross‐sectional descriptive meta‐research … S Ruzive, H Theunissen, S Durão, ME Visser, CE Naude Cochrane Evidence Synthesis and Methods 2 (3), e12048, 2024 | | 2024 |
| Comparison of the frequency and phenotypic profile of Mycobacterium tuberculosis-specific CD4 T cells between the site of disease and blood in pericardial tuberculosis (vol 13 … E Du Bruyn, S Ruzive, P Howlett, M Cerrone, AJ Jacobs, CLS Arlehamn, ... FRONTIERS IN IMMUNOLOGY 14, 2023 | | 2023 |
| Corrigendum: Comparison of the frequency and phenotypic profile of Mycobacterium tuberculosis-specific CD4 T cells between the site of disease and blood in pericardial tuberculosis E Du Bruyn, S Ruzive, P Howlett, M Cerrone, AJ Jacobs, CSL Arlehamn, ... Frontiers in Immunology 14, 2023 | | 2023 |
| Blood and site of disease inflammatory profiles differ in HIV-1-infected pericardial tuberculosis patients H Mutavhatsindi, E Du Bruyn, S Ruzive, P Howlett, A Sher, ... bioRxiv, 2022.10. 21.513232, 2022 | | 2022 |
| Identifying gaps using the EPICOT+ framework and exploring the association between funding sources and author conclusions in primary nutrition research addressing non … S Ruzive Stellenbosch: Stellenbosch University, 2021 | | 2021 |
